FineMark National Bank & Trust Raises Position in SPDR S&P Biotech (NYSEARCA:XBI)

FineMark National Bank & Trust raised its position in SPDR S&P Biotech (NYSEARCA:XBI) by 7.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,210 shares of the exchange traded fund’s stock after buying an additional 360 shares during the period. FineMark National Bank & Trust’s holdings in SPDR S&P Biotech were worth $402,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in XBI. Boston Advisors LLC purchased a new position in SPDR S&P Biotech during the second quarter valued at $213,000. Meridian Wealth Management LLC purchased a new position in SPDR S&P Biotech during the second quarter valued at $432,000. Bray Capital Advisors increased its position in SPDR S&P Biotech by 120.3% in the second quarter. Bray Capital Advisors now owns 15,610 shares of the exchange traded fund’s stock valued at $1,205,000 after buying an additional 8,525 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its position in SPDR S&P Biotech by 61.7% in the second quarter. Russell Investments Group Ltd. now owns 49,141 shares of the exchange traded fund’s stock valued at $3,792,000 after buying an additional 18,746 shares during the last quarter.

SPDR S&P Biotech (NYSEARCA:XBI) opened at 74.95 on Friday. The company has a 50-day moving average price of $78.04 and a 200 day moving average price of $72.03. SPDR S&P Biotech has a 1-year low of $53.15 and a 1-year high of $82.38.

ILLEGAL ACTIVITY NOTICE: This story was published by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this story can be read at https://www.com-unik.info/2017/08/19/finemark-national-bank-trust-acquires-360-shares-of-spdr-sp-biotech-nysearcaxbi-updated-updated.html.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

What are top analysts saying about SPDR S&P Biotech? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for SPDR S&P Biotech and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit